Candesartan Tablets 16 mg (Candesartan Cilexetil)

Adult dose

Essential hypertension in adults: The recommended initial and maintenance dose is 8 to 16 mg of Candesartan Cilexetil, administered orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment at 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. Heart failure in adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, considering the patient's tolerance.

Child dose

The safety and efficacy in pediatric patients under 18 years of age have not been established.

This medication can cause serious harm to the fetus, especially during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. The medication should not be used in patients with known allergies to it or its components, pregnant or nursing women, patients with severe hepatic impairment or cholestasis, and patients with hereditary angioedema. Elderly patients, those with renal impairment, hyperkalemia, hepatic impairment, valvular heart disease, or renal artery stenosis should use this medication with caution. Side effects such as dizziness, back pain, respiratory infections, and others may occur, and rarely serious blood abnormalities, liver dysfunction, myalgia, or renal impairment may occur. Particularly in heart failure patients, side effects such as hypotension, hyperkalemia, and renal function impairment may occur, thus regular blood tests and monitoring are necessary. This medication may significantly lower blood pressure; if symptoms of sudden drops in blood pressure, fainting, or loss of consciousness occur, immediate consultation with healthcare professionals is required. When used with other antihypertensive medications or diuretics, caution is needed due to increased risk of side effects from interactions. Pregnant women or those planning to become pregnant should not take this medication, and nursing women are also advised to avoid it. Safety in children or adolescents under 18 years of age has not been established, and use is not recommended. Patients should be cautious when driving or operating machinery as dizziness or drowsiness may occur during treatment. In cases of overdose, symptoms such as hypotension, dizziness, and tachycardia may manifest, and emergency treatment should be sought immediately. This medication should be kept out of the reach of children and should not be transferred to another container for safety.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities combined with cough and fever, jaundice (yellowing of skin or eyes), systemic malaise, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis

Mild side effects

Dizziness, back pain, respiratory infections (upper respiratory infections, pharyngitis, rhinitis), fatigue, peripheral edema, chest pain, headache, bronchitis, cough, sinusitis, nausea, abdominal pain, diarrhea, vomiting, arthralgia, proteinuria, weakness, fever, paresthesia, dyspepsia, gastroenteritis, tachycardia, palpitations, increased creatine kinase, hyperglycemia, hypertriglyceridemia, hyperuricemia, myalgia, nosebleeds, anxiety, depression, drowsiness, dyspnea, rash, sweating

This medication should be stored in a tightly closed container to prevent exposure to air or moisture and is best kept at room temperature between 1°C and 30°C. This storage maintains the effectiveness and safety of the medication.

Appearance

Light pink-yellow tablets, round with a convex shape on both sides.

Package unit

30 tablets/bottle, 100 tablets/bottle